Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02661633 · ClinicalTrials.gov registry record
Objective Brain Function Assessment of mTBI/Concussion in High School Athletes
A clinical trial, sponsored by BrainScope Company.
- Completed
- Registry status
- 177
- Enrollment target
NCT02661633: Completed study, sponsored by BrainScope Company.
NCT02661633 is a clinical trial that has completed, run by BrainScope Company. The registered enrollment target is 177 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02661633 has completed, sponsored by BrainScope Company.
- COMPLETED
- Registry status
- 177 participants
- Enrollment target
Study Summary
This study (Part 2) is designed to build a database including EEG, neurocognitive performance, clinical symptoms, history and other relevant data, which will be used to derive a multimodal EEG based algorithm for the identification of concussion and tracking of recovery. In addition, neuroimaging will be conducted at time of injury and following Return to Play (RTP).
Primary Outcome
Create a database of all assessments including brain electrical activity (EEG), neurocognitive performance, balance, and clinical/symptom assessments, to support derivation of a multimodal brain function/concussion index.
Interventions
- DEVICE BrainScope Ahead 200iD
- DEVICE Advanced MRI Neuroimaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2016-01-29 |
| Est. Completion | 2017-07-31 |
What the finished NCT02661633 record still lists
NCT02661633 is an observational study that tracks outcomes without assigning an intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which BrainScope Ahead 200iD is the first listed.
NCT02661633 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02661633 about?
NCT02661633 is a clinical study titled "Objective Brain Function Assessment of mTBI/Concussion in High School Athletes". This study (Part 2) is designed to build a database including EEG, neurocognitive performance, clinical symptoms, history and other relevant data, which will be used to derive a multimodal EEG based algorithm for the identification of concussion and tracking of recovery. In addition, neuroimaging wi...
What is the current status of trial NCT02661633?
This trial is currently completed. The enrollment target is 177 participants. The study started on 2016-01-29. Estimated completion is 2017-07-31.
What interventions are being tested in trial NCT02661633?
The interventions under investigation include: BrainScope Ahead 200iD (DEVICE), Advanced MRI Neuroimaging (DEVICE).
Who is sponsoring clinical trial NCT02661633?
This trial is sponsored by BrainScope Company, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI